Office-based Validation of the JVPHome
1 other identifier
observational
60
1 country
1
Brief Summary
The JVPHome is a novel medical device that utilizes machine vision in order to facilitate assessment of jugular venous pressure (JVP) height relative to the sternal angle with the ultimate goal of enabling remote JVP monitoring. The current study aims to evaluate the ability of an enhanced version of the JVPHome to enable remote identification of JVP height relative to ultrasound among congestive heart failure (CHF) patients when the device is applied by the study team in the clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2021
CompletedStudy Start
First participant enrolled
November 29, 2021
CompletedFirst Posted
Study publicly available on registry
January 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2023
CompletedJuly 28, 2022
July 1, 2022
11 months
November 29, 2021
July 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of JVP assessment using the JVPHome
Correlation between JVP height assessed by JVPHome and ultrasound Correlation between JVP height assessed by JVPHome and ultrasound Correlation between JVP height assessed by JVPHome and ultrasound
Day 1
Secondary Outcomes (3)
Electrocardiographic Assessment
Day 1
Pulse Oximetry Assessment
Day 1
Respiratory Rate
Day 1
Study Arms (1)
Ambulatory CHF patients
Patients visiting an outpatient CHF clinic
Interventions
Remote clinician assessment of JVP height using the JVPHome, and ultrasound based assessment of JVP height in the same patients.
Eligibility Criteria
Ambulatory CHF outpatients followed at the specialty heart failure clinic at Eastern Health in St. John's, Newfoundland and Labrador, Canada
You may qualify if:
- Age \>/= 18 years
- Congestive heart failure diagnosis receiving ongoing treatment
- Able to provide informed consent
You may not qualify if:
- Conditions which preclude visualization of the JVP, including neck deformity, scarring, and facial hair
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eastern Regional Health Authoritylead
- JVPLabscollaborator
Study Sites (1)
Eastern Health
St. John's, Newfoundland and Labrador, A1B 2X5, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kris Aubrey-Bassler, MD
Eastern Health
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2021
First Posted
January 18, 2022
Study Start
November 29, 2021
Primary Completion
November 3, 2022
Study Completion
January 3, 2023
Last Updated
July 28, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share